Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr881 Inhibitors

Olfr881, an olfactory receptor belonging to the G-protein-coupled receptor (GPCR) family, plays a crucial role in the olfactory system of the house mouse. Olfactory receptors like Olfr881 are responsible for detecting odorant molecules, initiating a neuronal response that culminates in the perception of smell. The structure of these receptors includes seven transmembrane domains, a feature they share with many neurotransmitter and hormone receptors. The activation of Olfr881 by specific odorants triggers a signaling cascade through G protein-mediated transduction, leading to various cellular responses. The inhibition of Olfr881's function, whether directly or indirectly, entails influencing the receptor's activity or the signaling pathways associated with it. Direct inhibition would involve compounds that bind to the receptor, preventing its activation by odorants. However, given the specificity and complexity of olfactory receptors, direct inhibitors are challenging to identify. Therefore, the focus shifts to indirect methods of inhibition, which primarily involve modulating the pathways and processes that influence Olfr881's function.

In the context of GPCRs like Olfr881, indirect inhibitors can operate through various mechanisms. These include altering intracellular messenger levels (like cAMP), modulating the activity of enzymes that affect receptor function (such as carbonic anhydrase), and influencing neurotransmitter systems that interact with GPCR signaling. For example, compounds that affect neurotransmitter availability or receptor sensitivity in the olfactory bulb can indirectly modify the response of Olfr881 to odorants. Additionally, the overall neuronal excitability and intracellular environment, which are crucial for GPCR function, can be modulated by different pharmacological agents to achieve indirect inhibition. It's important to recognize that these indirect methods do not target Olfr881 specifically but rather influence broader signaling networks and cellular processes that, in turn, impact the receptor's function. This approach is particularly relevant given the extensive interconnectivity of GPCRs and the intricate nature of olfactory signaling. The inhibitors listed above, therefore, represent a range of compounds that, through their action on various neurotransmitter systems and cellular processes, have the potential to indirectly influence the function of Olfr881.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol is a non-selective beta-adrenergic receptor antagonist. Its action on these receptors influences adenylate cyclase activity and reduces cAMP levels, potentially modulating GPCR signaling pathways such as those mediated by Olfr881.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$50.00
$168.00
$520.00
2
(1)

Yohimbine is an alpha-2 adrenergic receptor antagonist. By blocking these receptors, it increases synaptic norepinephrine levels, which could indirectly affect the signaling pathways of GPCRs like Olfr881 through crosstalk mechanisms.

Reserpine

50-55-5sc-203370
sc-203370A
1 g
5 g
$134.00
$406.00
1
(2)

Reserpine is an inhibitor of the vesicular monoamine transporter 2 (VMAT2), leading to depletion of monoamine neurotransmitters. This depletion can indirectly influence GPCR signaling, including Olfr881, by modulating the neuronal excitability and neurotransmitter availability.

Rauwolscine • HCl

6211-32-1sc-200151
100 mg
$105.00
(1)

Rauwolscine acts as an alpha-2 adrenergic receptor antagonist, similar to yohimbine. It enhances norepinephrine release, potentially modulating GPCR-mediated signaling pathways, including those involving Olfr881, by altering neurotransmitter dynamics.

Atropine

51-55-8sc-252392
5 g
$200.00
2
(1)

Atropine is a muscarinic acetylcholine receptor antagonist. By inhibiting these receptors, atropine can indirectly influence GPCR signaling pathways, including those of olfactory receptors like Olfr881, through cholinergic modulation.

Haloperidol

52-86-8sc-507512
5 g
$190.00
(0)

Haloperidol is a dopamine receptor antagonist primarily targeting D2 receptors. Its action on dopamine signaling can indirectly influence GPCR pathways, potentially affecting the function of receptors like Olfr881 in the olfactory system.

Ketanserin

74050-98-9sc-279249
1 g
$700.00
(0)

Ketanserin is a serotonin 5-HT2A receptor antagonist. By modulating serotonin signaling, it can indirectly influence GPCR-mediated pathways, including those of olfactory receptors like Olfr881, by affecting neurotransmitter balance.

Clonidine

4205-90-7sc-501519
100 mg
$235.00
1
(0)

Clonidine is an alpha-2 adrenergic agonist, which paradoxically reduces norepinephrine release. This reduction can indirectly influence GPCR signaling, including the pathways of olfactory receptors like Olfr881.

Metoprolol Tartrate

56392-17-7sc-205751
sc-205751A
5 g
25 g
$105.00
$238.00
3
(1)

Metoprolol is a selective beta-1 adrenergic receptor antagonist. It reduces cAMP levels in cells, potentially modulating GPCR-mediated signaling pathways such as those involving Olfr881 in the olfactory system.